What is Fluvoxamine primarily indicated for?

Fluvoxamine is primarily indicated for the treatment of Obsessive-Compulsive Disorder (OCD). This selective serotonin reuptake inhibitor (SSRI) has been shown to be effective in reducing the symptoms associated with OCD, helping individuals manage their intrusive thoughts and compulsive behaviors. Its mechanism as an SSRI enhances levels of serotonin in the brain, which plays a crucial role in mood regulation and anxiety management.

While Fluvoxamine can also have efficacy in treating other conditions such as Social Anxiety Disorder and Depression, its primary indication is specifically for OCD, which has made it a cornerstone in the treatment protocols for this disorder. This targeted action is particularly beneficial as it addresses the core symptoms directly associated with OCD, leading to significant improvements in the quality of life for those affected.